Phase I/II trial of weekly docetaxel and cisplatin for locoregional recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)

Trial Profile

Phase I/II trial of weekly docetaxel and cisplatin for locoregional recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)

Completed
Phase of Trial: Phase I/II

Latest Information Update: 03 Feb 2010

At a glance

  • Drugs Cisplatin; Docetaxel
  • Indications Head and neck cancer
  • Focus Adverse reactions
  • Sponsors Sanofi
  • Most Recent Events

    • 12 Jan 2007 Status change
    • 12 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top